Cite

HARVARD Citation

    Alegre, A. et al. (2020). Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple Myeloma. HemaSphere. 4 (3), pp. e380-. [Online]. 
  
Back to record